Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

INTERCEPT PHARMA EUROPE LTD. Active

Automotive


Contact information


This information is available only for subscribed users

Subscribe

Financial statements of INTERCEPT PHARMA EUROPE LTD.

According to INTERCEPT PHARMA EUROPE LTD. latest financial report submitted on 2020-12-31, the company has a Turnover of £245M, Gross-Profit of £242M while the Cash is £5M. Compared with the previous year, the company reported a Turnover increase of 21.1%, which is an equivalent of -51792646. At the same time, the Gross-Profit went up by 20.96%, or by -50755493.



Consolidated A/cs

For more information you can

Upgrade plan

Turnover 2020

£ 245.5 million

  • Consolidated A/cs

    N

  • Reporting period

    12

  • Working Capital

    £ -226.5 million

  • Profit after Tax

    £ -117.1 million

Reporting period Full financial info

INTERCEPT PHARMA EUROPE LTD. Business Credit Report

A Business Credit Report for INTERCEPT PHARMA EUROPE LTD. is available for instant download. The report will provide you with a credit score and credit limit recommendation for INTERCEPT PHARMA EUROPE LTD., payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

INTERCEPT PHARMA EUROPE LTD.

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

INTERCEPT PHARMA EUROPE LTD. Directors and key executives

View all employees

INTERCEPT PHARMA EUROPE LTD. currently employs 58 people. Compared with the previous year, the company has reported a staff increase of 14%, which is an equivalent of 7 employees.
In order to view contact information, including emails and phone numbers for all the employees working at INTERCEPT PHARMA EUROPE LTD. and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

58

114%

1y growth

119%

2y growth

Management Level


100

Middle

×
Employee Job Title Email Phone Country
Michael Gemellaro Director
-
- GB
Rocco Venezia Director
-
- GB
Linda Richardson Director
-
- GB
Willem Van Weperen Director
-
- GB
Daniel Hood Director
-
- GB

Get in touch with 6 of contacts working at INTERCEPT PHARMA EUROPE LTD.

Upgrade to subscription

INTERCEPT PHARMA EUROPE LTD. Ownership and Group Structure

View full group structure

INTERCEPT PHARMA EUROPE LTD. is a subsidiary of INTERCEPT PHARM************** which is a holding company, with the following registration number 09224395. The holding group consists of a total of 5 companies, including INTERCEPT PHARM**************, INTERCEPT PHARM*************, INTERCEPT PHARMA ****************, INTERCEPT P*********, INTERCEPT PHARMA INT******************.


INTERCEPT PHARMA EUROPE LTD. Shareholders

View all shareholders

There are currently 1 people with significant control at INTERCEPT PHARMA EUROPE LTD.. One of of major shareholders of INTERCEPT PHARMA EUROPE LTD. is INTERCEPT PHARMACEUTICALS INC., which owns 241 ORDINARY shares, with a total value of 241 GBP.


Name Quantity Share Type Value
INTERCEPT PHARMACEUTICALS INC. 241 ORDINARY 241 GBP

INTERCEPT PHARMA EUROPE LTD. competitors:

View all competitors

Top 5 similar companies of INTERCEPT PHARMA EUROPE LTD. are GALEN LIMITED, WAYMADE PLC, FGX EUROPE LIMITED, MCKESSON GLOBAL PROCUREMENT & SOURCING LIMITED, DIURNAL LIMITED. View and export all the competitor list of INTERCEPT PHARMA EUROPE LTD. by upgrading your account here.


GALEN LIMITED


Revenue
52,061,506.0
Age
17 years
Employees
36
Industry
View Pharmaceutical & Medical
Website
View http://galen***********

WAYMADE PLC


Revenue
28,641,000.0
Age
38 years
Employees
93
Industry
View Pharmaceutical & Medical
Website
View http://www.wa***********

FGX EUROPE LIMITED


Revenue
6,553,643.0
Age
25 years
Employees
50
Industry
View Automotive Repair & Maintenance
Website
View http://foster***********

MCKESSON GLOBAL PROCUREMENT & SOURCING LIMITED


Revenue
46,301,845.81
Age
9 years
Employees
37
Industry
View Pharmaceutical & Medical
Website
View -

DIURNAL LIMITED


Revenue
5,437,000.0
Age
18 years
Employees
21
Industry
View Scientific & Education
Website
View http://diur*********

INTERCEPT PHARMA EUROPE LTD. news & activities:

View full activity

Turnover

INTERCEPT PHARMA EUROPE LTD. has submitted new account statements and has reported a turnover of £245M, a 21.1% decrease year-over-year.

uk.globaldatabase.com

2020-12-31

EBITDA

The INTERCEPT PHARMA EUROPE LTD.-based company said the adjusted EBITDA is now -£134M, compared with the previous year of -72167867.

uk.globaldatabase.com

2020-12-31

Employees

INTERCEPT PHARMA EUROPE LTD. number of employees has increased by 14% compared with previous year and now represents a total number of 58.

uk.globaldatabase.com

2020-12-31

Frequently Asked Questions regarding INTERCEPT PHARMA EUROPE LTD.


Where is INTERCEPT PHARMA EUROPE LTD. registered office?

INTERCEPT PHARMA EUROPE LTD. is located at ONE GLASS WHARF BRISTOL, United Kingdom.

How many people work at INTERCEPT PHARMA EUROPE LTD.?

According to the latest account statement, there are currently 58 of employees working for INTERCEPT PHARMA EUROPE LTD..

How much revenue does INTERCEPT PHARMA EUROPE LTD. make?

Based on the latest financial accounts submitted on 2020-12-31, the company made £245M for 2020, which went up by 21.1%.

What is INTERCEPT PHARMA EUROPE LTD. EBITDA?

For 2020, INTERCEPT PHARMA EUROPE LTD. has reported an EBITDA of -£134M, which went down by -46.02% compared to previous year.

What is the Business Credit Score of INTERCEPT PHARMA EUROPE LTD. and how reliable is the company?

In order to check the business credit score of INTERCEPT PHARMA EUROPE LTD, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does INTERCEPT PHARMA EUROPE LTD. pay their invoices on time?

By requesting a Business Credit Report for INTERCEPT PHARMA EUROPE LTD, you will be able to gain more insights about the INTERCEPT PHARMA EUROPE LTD. payment trends.

Who is the Ultimate Parent of the INTERCEPT PHARMA EUROPE LTD.?

Information about the ultimate beneficial ownership INTERCEPT PHARM************** of INTERCEPT PHARMA EUROPE LTD. is available when you order a business credit report.

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action